These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2506515)

  • 1. [Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose].
    Guibert J; Kitzis MD; Acar JF; Masquelier AM; Bellanger B
    Pathol Biol (Paris); 1989 May; 37(5):411-4. PubMed ID: 2506515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose].
    Guibert J; Kitzis MD; Brumpt I; Acar JF
    Pathol Biol (Paris); 1989 May; 37(5):406-10. PubMed ID: 2506514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose].
    Guibert J; Kitzis MD; Acar JF
    Pathol Biol (Paris); 1994 Jun; 42(6):587-92. PubMed ID: 7854859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg].
    Guibert J; Kitzis MD; Acar JF
    Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity of urine after administration of ofloxacin for 5 days].
    Drugeon H; Veyries ML; Levacher M; Garnier M; Aymard G; Giroud JP; Rouveix B
    Therapie; 2000; 55(6):691-7. PubMed ID: 11234464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.
    García-Calvo G; Parra A; Aguilar L; Ponte C; Giménez MJ; Carcas A; Kinzig-Schippers M; Soriano F
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1876-8. PubMed ID: 11353641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
    Staib AH; Harder S; Fuhr U; Wack C
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):289-3. PubMed ID: 2737798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
    Zhao M; Jiang S; Wang R
    Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):98-100. PubMed ID: 11798634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and relative bioavailability of lomefloxacin preparations in 10 healthy Chinese volunteers.
    Diao Y; Lu J; Li L; Zhu XD; Ji G; Wang EH
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):247-9. PubMed ID: 8237402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model.
    Rustige C; Wiedemann B
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1107-11. PubMed ID: 2118324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the emergence of resistance to lomefloxacin in vitro.
    Kanematsu M; Greenwood D
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):741-5. PubMed ID: 2506046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
    Leigh DA; Harris C; Tait S; Walsh B; Hancock P
    J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary bactericidal activity of single doses (250, 500, 750 and 1000 mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli.
    Stein GE; Schooley SL; Nicolau DP
    Int J Antimicrob Agents; 2008 Oct; 32(4):320-5. PubMed ID: 18715762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution from 1976 to 1986 of bacterial prevalence and sensitivity to urinary antibiotics of bacteria isolated from urine cultures at a city microbiology laboratory].
    Chouteau J
    Pathol Biol (Paris); 1988 May; 36(5):439-41. PubMed ID: 3136425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
    Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
    Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.